Acasti Pharma Inc (NASDAQ:ACST)
| 0.73 Delayed Data As of Jan 30 |  +0.0159 / +2.23%Today’s Change | 0.34 Today|||52-Week Range 1.35 | +45.71% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | |||
| Revenue and Income | Net Revenues | 28.8K | 0.00 | 0.00 | 0.00 | |
| Cost of Goods Sold | 62.3K | 0.00 | 0.00 | 0.00 | ||
| Depreciation And Amortization | 1.8M | 1.9M | 2.1M | 2.2M | ||
| Operating Expenses | Gross Income | -1.9M | -1.9M | -2.1M | -2.2M | |
| General Expenses | 5.4M | 6.0M | 13.6M | 31.9M | ||
| Research And Development | 3.7M | 5.4M | 10.4M | 27.5M | ||
| Total Operating Expenses | 7.3M | 7.9M | 15.7M | 34.0M | ||
| Non-Operating Expenses | Operating Income | -7.2M | -7.9M | -15.7M | -34.0M | |
| Extraordinary Credit | 1.7M | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Charge | -259.5K | -40.4K | -268.0K | -5.5M | ||
| Interest Expense On Debt | 0.00 | 40.8K | 288.3K | 278.2K | ||
| Other Expenses | 780.7K | -123.5K | -908.5K | -285.1K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -5.0M | -8.0M | -17.1M | -39.8M | |
| Income Taxes | -129.2K | -90.7K | -318.7K | -448.2K | ||
| Net Income | -4.8M | -7.9M | -16.8M | -39.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 10.7M | 11.1M | 17.5M | 54.3M | |
| Shares To Calculate EPS Diluted | 10.7M | 11.1M | 17.5M | 54.3M | ||
| Earnings Per Share | EPS | -$0.45 | -$0.77 | -$0.96 | -$0.72 | |
| EPS Diluted | -$0.45 | -$0.71 | -$0.96 | -$0.72 | ||
